---
gsd_state_version: 1.0
milestone: v3.1
milestone_name: milestone
status: verifying
last_updated: "2026-06-12T18:21:23.327Z"
last_activity: 2026-06-12
progress:
  total_phases: 4
  completed_phases: 3
  total_plans: 3
  completed_plans: 3
  percent: 100
---

# Project State

## Project Reference

See: .planning/PROJECT.md (updated 2026-06-12)

**Core value:** A working cohort filter chain that reads like a clinical protocol — with logged attrition at every step and clear payer-stratified visualizations showing how patients flow from enrollment through diagnosis to treatment.

**Current focus:** Phase 102 — single-agent-co-administration-analysis

## Current Position

Phase: 103
Plan: Not started
Status: Phase complete — ready for verification
Last activity: 2026-06-12

Progress: [██████████████████████████████████████████] 100%

## Performance Metrics

**Milestone velocity:**

- v3.0: 5 phases (95-99) completed in 3 days (2026-06-09 to 2026-06-11)
- v2.3: 4 phases completed in 2 days
- v2.2: 7 phases completed in 3 days

**Planning efficiency:**

- Average plans per phase: 1.5
- Average tasks per plan: 3-5

## Accumulated Context

### Recent Decisions

**v3.1 Roadmap decisions:**

- Phase numbering continues from Phase 99 (v3.0 last phase) → v3.1 starts at Phase 100
- Granularity: coarse (4 phases for 9 requirements)
- Phase dependency: CONDITION linkage (Phase 100) BEFORE broadened drug grouping (Phase 101) so improved linkage rates benefit the broadened output's cancer_linked flag accuracy
- Death date cross-tabs (Phase 103) and co-administration (Phase 102) are independent analyses

**Milestone v3.0 decisions:**

- Full data.table adoption (reverses original stack constraint that avoided data.table for readability)
- Hybrid approach: data.table for hot paths, preserve dplyr in cohort filters (has_*, with_*, exclude_* named predicates)
- Scope: 6 lookup tables, 3 hot-path scripts (R/60, R/28, R/02), classify_payer_tier_dt() function
- Output correctness must be preserved (results match pre-optimization)

**Phase 99 decisions:**

- Use str_detect for is_hodgkin derivation instead of CANCER_SITE_MAP re-query (simpler, preserves upstream Phase 61 logic)
- Empty strings for pseudo-treatment character enrichment columns, NA for logical is_first_line (Tableau filter clarity)
- Dynamic schema verification checks replace hardcoded column count checks in R/88
- R/51 deletion verified via !file.exists() check

**Phase 100 decisions:**

- CONDITION table as 3rd-tier cancer linkage supplement using read-only investigation pattern (D-06, D-07, D-08)
- ONSET_DATE (not REPORT_DATE) for temporal matching - clinical onset aligns better with treatment timing (D-04)
- Link method labels "condition_encounter" and "condition_date" parallel to R/28 DIAGNOSIS labels for comparison clarity (D-03)
- Treatment type breakdown (D-10) enables targeted improvement analysis per treatment category
- Decision traceability in script header (D-01 through D-10) documents all investigation design choices

**Phase 101 decisions:**

- cancer_linked derived from !is.na(cancer_codes) for encounter-level DX presence flag (D-03)
- Broadened output = primary files; linked-only with _linked_only suffix (D-07, D-08)
- Cross-tab summary as 3rd sheet "Linked vs Unlinked" in broadened workbook (D-06)
- select(-cancer_linked) strips flag from linked-only exports for backward compatibility
- 4 separate output paths prevent file overwriting (NEW/OLD broadened + NEW/OLD linked-only)

**Phase 102 decisions:**

- data.table cartesian join for temporal self-join (consistent with Phase 95-99 patterns)
- 4-tier drug name resolution: xlsx > CODE_SUBCATEGORY_MAP > drug_name > triggering_code
- Signed days_apart preserves temporal direction for sequence analysis
- All pairs shown in xlsx (not top N); console log shows top 10 for quick review

### Roadmap Evolution

**v3.1 Structure:**

- Phase 100: CONDITION Table Cancer Linkage (COND-01, COND-02, COND-03)
- Phase 101: Broadened Drug Grouping Output (DRUG-01, DRUG-02, DRUG-03)
- Phase 102: Single-Agent Co-Administration Analysis (COADMIN-01, COADMIN-02)
- Phase 103: Death Date Cross-Tab Summary (DEATH-01)

**Coverage:** 9/9 v3.1 requirements mapped (100%)

### Open Questions

None currently identified.

### Active TODOs

- [ ] Plan Phase 100 (CONDITION Table Cancer Linkage) - 3rd tier in cancer linkage cascade
- [ ] Execute Phase 100 to reduce unlinked episode rate from ~30% to <20%
- [ ] Plan Phase 101 (Broadened Drug Grouping) after Phase 100 completes
- [ ] Plan Phase 102 (Co-Administration Analysis) after Phase 101 completes
- [ ] Plan Phase 103 (Death Date Cross-Tabs) - independent, can execute anytime

### Known Blockers

None identified.

## Session Continuity

**Last command:** `/gsd:execute-phase 102` (Phase 102 execution)
**What's next:** Run `/gsd:plan-phase 103` to create execution plans for death date cross-tab summary

### Recent Changes

- 2026-06-12: Phase 102 Plan 01 complete (co-administration analysis, 2 tasks, 2 commits)
- 2026-06-12: Phase 101 Plan 01 complete (broadened drug grouping output, 2 tasks, 2 commits)
- 2026-06-12: v3.1 milestone started after defining requirements
- 2026-06-12: Roadmap created with 4 phases (100-103) covering 9 requirements
- 2026-06-11: v3.0 Phase 99 completed (Gantt consolidation with dynamic schema verification)
- 2026-06-11: v3.0 Phase 97 completed (R/60 hot-path migration to data.table)
- 2026-06-10: v3.0 Phase 95-96 completed (data.table infrastructure and classify_payer_tier_dt)

### Key Files Modified

**Phase 102 (Single-Agent Co-Administration Analysis):**

- Created: R/58_co_administration_analysis.R (375-line investigation script)
- Modified: R/88_smoke_test_comprehensive.R (Section 31B with 17 checks)
- Created: .planning/phases/102-single-agent-co-administration-analysis/102-01-SUMMARY.md

**Phase 101 (Broadened Drug Grouping Output):**

- Modified: R/57_drug_grouping_instances.R (dual-output with cancer_linked flag, cross-tab summary)
- Modified: R/88_smoke_test_comprehensive.R (Phase 101 validation section)
- Created: .planning/phases/101-broadened-drug-grouping-output/101-01-SUMMARY.md

**v3.1 Roadmap Creation:**

- Created: .planning/ROADMAP.md (v3.1 roadmap replacing v3.0 content)
- Updated: .planning/STATE.md (v3.1 milestone tracking)
- Ready to update: .planning/REQUIREMENTS.md (traceability section pending)

**v3.0 Completion (Phases 95-99):**

- Phase 99: R/52 schema consolidation, R/88 updates, R/99 validation script, R/51 deletion
- Phase 96: classify_payer_tier_dt() in utils_payer.R, R/96 validation script
- Phase 95: utils_dt.R, LOOKUP_TABLES_DT in R/00_config.R, R/95 validation script

### Outstanding Work

**Immediate (v3.1):**

- Phase 100: CONDITION table cancer linkage (3 requirements)
- ~~Phase 101: Broadened drug grouping output (3 requirements)~~ COMPLETE
- ~~Phase 102: Single-agent co-administration analysis (2 requirements)~~ COMPLETE
- Phase 103: Death date cross-tab summary (1 requirement)

**Deferred from v3.0:**

- Phase 98 Plan 02: R/98 validation script and R/88 full smoke test (1 of 2 plans pending)

---
*State updated: 2026-06-12 after Phase 102 Plan 01 completion*
